Next Article in Journal
Phenolic Profile and Biological Activities of the Pepino (Solanum muricatum) Fruit and Its Wild Relative S. caripense
Next Article in Special Issue
Exploring Erythropoietin and G-CSF Combination Therapy in Chronic Stroke Patients
Previous Article in Journal
Ionogels Based on Poly(methyl methacrylate) and Metal-Containing Ionic Liquids: Correlation between Structure and Mechanical and Electrical Properties
Previous Article in Special Issue
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology
Open AccessArticle

Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke

1
Department of Neurology, Hospital Vall d’Hebron, Universitat Autónoma de Barcelona, Barcelona 08035, Spain
2
Department of Psychiatry, Hospital Vall d’Hebron, Universitat Autónoma de Barcelona, Barcelona 08035, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Katalin Prokai-Tatrai
Int. J. Mol. Sci. 2016, 17(3), 390; https://doi.org/10.3390/ijms17030390
Received: 21 January 2016 / Revised: 4 March 2016 / Accepted: 7 March 2016 / Published: 16 March 2016
(This article belongs to the Special Issue Neuroprotective Strategies 2016)
Stroke, as the leading cause of physical disability and cognitive impairment, has a very significant impact on patients’ quality of life (QoL). The objective of this study is to know the effect of citicoline treatment in Qol and cognitive performance in the long-term in patients with a first ischemic stroke. This is an open-label, randomized, parallel study of citicoline vs. usual treatment. All subjects were selected 6 weeks after suffering a first ischemic stroke and randomized into parallel arms. Neuropsychological evaluation was performed at 1 month, 6 months, 1 year and 2 years after stroke, and QoL was measured using the EuroQoL-5D questionnaire at 2 years. 163 patients were followed during 2 years. The mean age was 67.5 years-old, and 50.9% were women. Age and absence of citicoline treatment were independent predictors of both utility and poor quality of life. Patients with cognitive impairment had a poorer QoL at 2 years (0.55 vs. 0.66 in utility, p = 0.015). Citicoline treatment improved significantly cognitive status during follow-up (p = 0.005). In conclusion, treatment with long-term citicoline is associated with a better QoL and improves cognitive status 2 years after a first ischemic stroke. View Full-Text
Keywords: quality of life; ischemic stroke; citicoline; cognitive impairment quality of life; ischemic stroke; citicoline; cognitive impairment
Show Figures

Graphical abstract

MDPI and ACS Style

Alvarez-Sabín, J.; Santamarina, E.; Maisterra, O.; Jacas, C.; Molina, C.; Quintana, M. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. Int. J. Mol. Sci. 2016, 17, 390. https://doi.org/10.3390/ijms17030390

AMA Style

Alvarez-Sabín J, Santamarina E, Maisterra O, Jacas C, Molina C, Quintana M. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke. International Journal of Molecular Sciences. 2016; 17(3):390. https://doi.org/10.3390/ijms17030390

Chicago/Turabian Style

Alvarez-Sabín, Jose; Santamarina, Estevo; Maisterra, Olga; Jacas, Carlos; Molina, Carlos; Quintana, Manuel. 2016. "Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke" Int. J. Mol. Sci. 17, no. 3: 390. https://doi.org/10.3390/ijms17030390

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop